High-dose Inhaled NO Therapy for the Prevention of Nosocomial Pneumonia After Cardiac Surgery With CPB
Status:
Completed
Trial end date:
2024-02-06
Target enrollment:
Participant gender:
Summary
The primary aim of this single-center, prospective, randomized, controlled, pilot study is to
test the hypothesis that inhalation of NO 200 ppm prevents the development of nosocomial
pneumonia in patients at risk after cardiac surgery with CPB. The study is interventional.
Examination and treatment of patients is carried out in accordance with the approved
standards of medical care for the relevant diseases. During the study, no experimental or
unregistered (not approved for use) medical or diagnostic procedures in the territory of the
Russian Federation will be carried out. The study includes patients admitted to the Cardiac
Surgery Department of Cardiology Research Institute of Tomsk National Research Medical Center
for elective surgery with CPB.
Phase:
N/A
Details
Lead Sponsor:
Tomsk National Research Medical Center of the Russian Academy of Sciences